The FASEB Journal, Vol 9, 659-664, Copyright © 1995 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo

B Schobitz, G Pezeshki, T Pohl, U Hemmann, PC Heinrich, F Holsboer and JM Reul
Max Planck Institute of Psychiatry, Clinical Institute, Munich, Germany.

The pleiotropic cytokine interleukin-6 (IL-6) controls both the peripheral and central components of the acute-phase response. These activities are mediated via the IL-6 membrane receptor, but probably also via agonistic soluble IL-6 receptors (sIL-6Rs). In the present study we conducted dose-response experiments with rats that were intracerebroventricularly i.c.v.) injected with recombinant human IL-6 and sIL-6R and determined body temperature, locomotor activity, food intake, and water consumption using radiotelemetry and continuous recordings of feeding and drinking. IL-6 injected i.c.v. at 1, 10, and 100 ng increased body temperature and decreased locomotor activity and food intake, but it did not affect water consumption. When 10 ng sIL- 6R, which lacked detectable biological activity, was injected i.c.v. 1 h before 1 ng IL-6, the central effects of IL-6 were enhanced and prolonged, and this was not due to endotoxin contamination of the recombinant proteins. Our data suggest that IL-6 plays an important role in the regulation of body temperature, general activity, and food intake in sick animals. Moreover, we have shown for the first time that it is possible to potentiate the effects of a mediator in vivo by administration of the corresponding receptor, which is a novel pharmacological tool for increasing receptor capacity.

This article has been cited by other articles:

				S. Dimitrov, T. Lange, C. Benedict, M. A. Nowell, S. A. Jones, J. Scheller, S. Rose-John, and J. Born Sleep enhances IL-6 trans-signaling in humans FASEB J, October 1, 2006; 20(12): 2174 - 2176. [Abstract] [Full Text] [PDF]

				T Gustot, A Lemmers, E Louis, C Nicaise, E Quertinmont, J Belaiche, S Roland, A Van Gossum, J Deviere, and D Franchimont Profile of soluble cytokine receptors in Crohn's disease Gut, April 1, 2005; 54(4): 488 - 495. [Abstract] [Full Text] [PDF]

				D. Acalovschi, T. Wiest, M. Hartmann, M. Farahmi, U. Mansmann, G. U. Auffarth, A. J. Grau, F. R. Green, C. Grond-Ginsbach, and M. Schwaninger Multiple Levels of Regulation of the Interleukin-6 System in Stroke Stroke, August 1, 2003; 34(8): 1864 - 1869. [Abstract] [Full Text] [PDF]

				A. V. Turnbull, S. Prehar, A. R. Kennedy, R. A. Little, and S. J. Hopkins Interleukin-6 Is an Afferent Signal to the Hypothalamo-Pituitary-Adrenal Axis during Local Inflammation in Mice Endocrinology, May 1, 2003; 144(5): 1894 - 1906. [Abstract] [Full Text] [PDF]

				S. A. JONES, S. HORIUCHI, N. TOPLEY, N. YAMAMOTO, and G. M. FULLER The soluble interleukin 6 receptor: mechanisms of production and implications in disease FASEB J, January 1, 2001; 15(1): 43 - 58. [Abstract] [Full Text] [PDF]

				W. Van Molle, T. Hochepied, P. Brouckaert, and C. Libert The Major Acute-Phase Protein, Serum Amyloid P Component, in Mice Is Not Involved in Endogenous Resistance against Tumor Necrosis Factor Alpha-Induced Lethal Hepatitis, Shock, and Skin Necrosis Infect. Immun., September 1, 2000; 68(9): 5026 - 5029. [Abstract] [Full Text] [PDF]

				P. W. Zandstra, D. A. Lauffenburger, and C. J. Eaves A ligand-receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesis Blood, August 15, 2000; 96(4): 1215 - 1222. [Abstract] [Full Text] [PDF]

				M. J. P. Lenczowski, R.-M. Bluthe, J. Roth, G. S. Rees, D. A. Rushforth, A.-M. van Dam, F. J. H. Tilders, R. Dantzer, N. J. Rothwell, and G. N. Luheshi Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R652 - R658. [Abstract] [Full Text] [PDF]

				L. R. Leon, A. A. White, and M. J. Kluger Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R269 - R277. [Abstract] [Full Text] [PDF]

				S. D. McKenna, F. Chen, L. Lai, and I. Goldschneider Identification of an IL-7-Associated Pre-Pro-B Cell Growth-Stimulating Factor (PPBSF). I. Production of the Non-IL-7 Component by Bone Marrow Stromal Cells from IL-7 Gene-Deleted Mice J. Immunol., March 1, 1998; 160(5): 2272 - 2279. [Abstract] [Full Text] [PDF]

				L. Lai, F. Chen, S. McKenna, and I. Goldschneider Identification of an IL-7-Associated Pre-Pro-B Cell Growth-Stimulating Factor (PPBSF). II. PPBSF Is a Covalently Linked Heterodimer of IL-7 and a Mr 30,000 Cofactor J. Immunol., March 1, 1998; 160(5): 2280 - 2286. [Abstract] [Full Text] [PDF]